Share on StockTwits

The Clorox (NYSE:CLX) CMO Thomas P. Britanik sold 1,779 shares of the company’s stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $88.48, for a total value of $157,405.92. Following the completion of the sale, the chief marketing officer now directly owns 11,808 shares in the company, valued at approximately $1,044,772. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of The Clorox (NYSE:CLX) traded up 0.26% on Wednesday, hitting $88.59. The stock had a trading volume of 565,935 shares. The Clorox has a 1-year low of $80.20 and a 1-year high of $96.76. The stock’s 50-day moving average is $89.03 and its 200-day moving average is $89.5. The company has a market cap of $11.392 billion and a price-to-earnings ratio of 20.53.

The Clorox (NYSE:CLX) last announced its earnings results on Thursday, May 1st. The company reported $1.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.08 by $0.03. The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company’s quarterly revenue was down 1.9% on a year-over-year basis. Analysts expect that The Clorox will post $4.33 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, August 8th. Shareholders of record on Wednesday, July 23rd will be paid a dividend of $0.74 per share. This represents a $2.96 annualized dividend and a dividend yield of 3.34%. The ex-dividend date is Monday, July 21st. This is a positive change from The Clorox’s previous quarterly dividend of $0.71.

CLX has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of The Clorox in a research note on Friday, May 16th. They now have a $93.00 price target on the stock. Separately, analysts at B. Riley cut their price target on shares of The Clorox from $85.00 to $79.00 in a research note on Monday, May 12th. They now have a “neutral” rating on the stock. Finally, analysts at BMO Capital Markets cut their price target on shares of The Clorox from $83.00 to $4.00 in a research note on Tuesday, May 6th. Four investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $80.70.

The Clorox Company (NYSE:CLX) is a manufacturer and marketer of consumer and professional products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.